Startup Profile: Lactiga (020)

Episode 20 September 05, 2021 00:48:50
Startup Profile: Lactiga (020)
Innovation4Alpha
Startup Profile: Lactiga (020)

Sep 05 2021 | 00:48:50

/

Show Notes

Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent mucosal infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. They are unlocking the full therapeutic value of human milk antibodies to create the next-generation of anti-infectives that can battle even the world’s most dangerous pathogens including Covid. Lactiga has earned multiple awards, media attention (Globe & Mail, CTV, Toronto Star) and is participating in the On Deck Health (ODH2) cohort.

AngelMD Profile: https://www.angelmd.co/en/startups/lactiga

Other Episodes

Episode 3

July 21, 2023 00:28:09
Episode Cover

Pathkeeper: Next Generation Surgical Robot

PathKeeper is an innovative robotic company founded in Israel.The company's disruptive, proprietary technology provides laser-like accuracy for spinal procedures. The unique technology tracks the...

Listen

Episode 14

May 21, 2022 00:18:54
Episode Cover

ScriptChain: Applying Artificial Intelligence to Chronic Heart Related Issues (214)

ScriptChain is a digital health platform that sits on top of EHR systems and requests patient medical data from the EHR, runs through the...

Listen

Episode 17

August 25, 2021 00:30:35
Episode Cover

Startup Profile: Elims (017)

Elims is a social impact company that combines seriously effective oral care + real sustainability. They believe you don't have to compromise your health...

Listen